Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor

Journal of General Virology

Volumn 87, Issue 6, 2006, Pages 1451-1458

  Chen, Ron A J ^a   Jacobs, Nathalie ^a   Smith, Geoffrey L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; PLASMID VECTOR; POLYCLONAL ANTISERUM; PROTEIN B14; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN; WESTERN RESERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; GENETIC TRAIT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VIVO STUDY; MAMMAL CELL; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; POXVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RABBIT; STUDENT T TEST; VACCINIA; VACCINIA VIRUS; VIROGENESIS; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CELL LINE; ESCHERICHIA COLI; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MUTATION; RABBITS; RECOMBINANT PROTEINS; SUBCELLULAR FRACTIONS; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE FACTORS;

ESCHERICHIA COLI; MAMMALIA; ORYCTOLAGUS CUNICULUS; POXVIRIDAE; VACCINIA VIRUS;

EID: 33744818439     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81736-0     Document Type: Article

References (36)

1. Alcami, A. & Smith, G. L. (1992). A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
2. Alcami, A. & Smith, G. L. (1996). A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A 93, 11029-11034.
3. Boyle, D. B. & Coupar, B. E. (1988). A dominant selectable marker for the construction of recombinant poxviruses. Gene 65, 123-128.
4. Carter, G. C., Rodger, G., Murphy, B. J., Law, M., Krauss, O., Hollinshead, M. & Smith, G. L. (2003). Vaccinia virus cores are transported on microtubules. J Gen Virol 84, 2443-2458.
5. Dobbelstein, M. & Shenk, T. (1996). Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J Virol 70, 6479-6485.
6. Falkner, F. G. & Moss, B. (1990). Transient dominant selection of recombinant vaccinia viruses. J Virol 64, 3108-3111.
7. Gillitzer, R. & Goebeler, M. (2001). Chemokines in cutaneous wound healing. J Leukoc Biol 69, 513-521.
8. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P. & Paoletti, E. (1990). The complete DNA sequence of vaccinia virus. Virology 179, 247-266, 517-263.
9. Gubser, C. & Smith, G. L. (2002). The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol 83, 855-872.
10. Gubser, C., Hue, S., Kellam, P. & Smith, G. L. (2004). Poxvirus genomes: a phylogenetic analysis. J Gen Virol 85, 105-117.
11. Howard, S. T., Chan, Y. S. & Smith, G. L. (1991). Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180, 633-647.
12. Hughes, S. J., Johnston, L. H., de Carlos, A. & Smith, G. L. (1991). Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J Biol Chem 266, 20103-20109.
13. Jacobs, N., Chen, R. A.-J., Gubser, C., Najarro, P. & Smith, G. L. (2006). Intradermal immune response after infection with vaccinia virus. J Gen Virol 87, 1157-1161.
14. Kettle, S., Alcami, A., Khanna, A., Ehret, R., Jassoy, C. & Smith, G. L. (1997). Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1β-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1β-induced fever. J Gen Virol 78, 677-685.
15. Kunstfeld, R., Lechleitner, S., Wolff, K & Petzelbauer, P. (1998). MCP-1 and MIP-1α are most efficient in recruiting T cells into the skin in vivo. J Invest Dermatol 111, 1040-1044.
16. Macara, I. G. (2001). Transport into and out of the nucleus. Microbiol Mol Biol Rev 65, 570-594.
17. Moss, B. (2001). Poxviridae: the viruses and their replication. In Virology, 4th edn, pp. 2849-2883. Edited by B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. Melnick, T. P. Monath, B. Roizman & S. E. Straus. Philadelphia: Lippincott-Raven Publishers.
18. Niles, E G. & Seto, J. (1988). Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol 62, 3772-3778.
19. r 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
20. Parkinson, J. E., Sanderson, C. M. & Smith, G. L. (1995). The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein. Virology 214, 177-188.
21. Pires de Miranda, M., Reading, P. C., Tscharke, D. C., Murphy, B. J. & Smith, G. L. (2003). The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol 84, 2459-2471.
22. Reading, P. C. & Smith, G. L (2003). A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84, 1973-1983.
23. 2+ influx into infected cells. J Virol 70, 905-914.
24. Schon, M. P., Zollner, T. M. & Boehncke, W. H. (2003). The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol 121, 951-962.
25. Seet, B. T., Johnston, J. B., Brunetti, C. R. & 7 other authors (2003). Poxviruses and immune evasion. Annu Rev Immunol 21, 377-423.
26. Smith, G. L. & McFadden, G. (2002). Smallpox: anything to declare? Nat Rev Immunol 2, 521-527.
27. Smith, G. L., Chan, Y. S. & Howard, S. T. (1991). Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J Gen Virol 72, 1349-1376.
28. Smith, G. L., Vanderplasschen, A. & Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83, 2915-2931.
29. Spriggs, M. K., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. & VanSlyke, J. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71, 145-152.
30. Tscharke, D. C. & Smith, G. L. (1999). A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80, 2751-2755.
31. Tscharke, D. C., Reading, P. C. & Smith, G. L. (2002). Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83, 1977-1986.
32. Upton, C., Slack, S., Hunter, A. L., Ehlers, A. & Roper, R. L. (2003). Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. J Virol 77, 7590-7600.
33. van Eijl, H., Hollinshead, M., Rodger, G., Zhang, W. H. & Smith, G. L. (2002). The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol 83, 195-207.
34. von Stebut, E., Metz, M., Milon, G., Knop, J. & Maurer, M. (2003). Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα. Blood 101, 210-215.
35. Williamson, J. D., Reith, R. W., Jeffrey, L. J., Arrand, J. R. & Mackett, M. (1990). Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71, 2761-2767.
36. Xu, L. & Massague, J. (2004). Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol 5, 209-219.